New prenatal blood test aims to detect genetic disorders without invasive procedures
NCT ID NCT07643896
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood test that looks for fetal cells in the mother's blood to detect genetic conditions like Down syndrome. The test will be compared to standard diagnostic methods such as amniocentesis or newborn testing. The study involves 1,000 pregnant individuals between 10 and 20 weeks of pregnancy with a single baby.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 22Q11.2 DELETION SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pediatrix Medical Group
RECRUITINGHouston, Texas, 773339, United States
-
Pediatrix Medical Group of Georgia
RECRUITINGAtlanta, Georgia, 30342, United States
-
San Gabriel Valley Perinatal Medical Group
RECRUITINGWest Covina, California, 91710, United States
-
Sarasota Memorial Health Care System
RECRUITINGSarasota, Florida, 34239, United States
-
Valley Perinatal Services
RECRUITINGPhoenix, Arizona, 85004, United States
-
Woman's Hospital
RECRUITINGBaton Rouge, Louisiana, 70817, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 'Abnormal' embryos still lead to healthy pregnancies? a new registry investigates
- Do Pre-Pregnancy Weight-Loss drugs change pregnancy outcomes?
- Hunting for hidden genes that shape a genetic Disorder's severity
- Could a pacifier help babies with down syndrome breathe better at night?
- Brain and eye clues to emotion recognition in autism and psychosis
- New study investigates hidden heart risks in down syndrome